0001144204-19-009923.txt : 20190225
0001144204-19-009923.hdr.sgml : 20190225
20190225173639
ACCESSION NUMBER: 0001144204-19-009923
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190219
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beebe Katherine
CENTRAL INDEX KEY: 0001768867
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 19630747
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD, SUITE 505
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
tv514643_3.xml
OWNERSHIP DOCUMENT
X0206
3
2019-02-19
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001768867
Beebe Katherine
400 OYSTER POINT BLVD., SUITE 505
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2387
D
Option (Right to Buy)
1.56
Common Stock
28487
D
Option (Right to Buy)
19.80
2025-03-16
Common Stock
4243
D
Option (Right to Buy)
5.82
2028-03-07
Common Stock
28335
D
Represents currently vested options that were granted between May 2009 and February 2017 that were repriced effective January 23, 2019. Of such options, 7,576 expire on May 17, 2019, with the balance expiring on various dates between May 11, 2021 and February 13, 2027.
These options, which were granted in March 2015, are fully vested.
These options, which were granted in March 2017, are fully vested.
/s/Katherine Beebe DeVarney
2019-02-25